JP2019537430A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019537430A5 JP2019537430A5 JP2019515986A JP2019515986A JP2019537430A5 JP 2019537430 A5 JP2019537430 A5 JP 2019537430A5 JP 2019515986 A JP2019515986 A JP 2019515986A JP 2019515986 A JP2019515986 A JP 2019515986A JP 2019537430 A5 JP2019537430 A5 JP 2019537430A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- oligonucleotide
- pmhc
- polynucleotide
- vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 171
- 108091008874 T cell receptors Proteins 0.000 claims description 168
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 167
- 108091033319 polynucleotide Proteins 0.000 claims description 160
- 239000002157 polynucleotide Substances 0.000 claims description 160
- 102000040430 polynucleotide Human genes 0.000 claims description 160
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 112
- 108091034117 Oligonucleotide Proteins 0.000 claims description 95
- 230000000295 complement effect Effects 0.000 claims description 66
- 210000004027 cell Anatomy 0.000 claims description 47
- 108020004999 messenger RNA Proteins 0.000 claims description 31
- 238000012163 sequencing technique Methods 0.000 claims description 22
- 238000001514 detection method Methods 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 8
- 108020004414 DNA Proteins 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 238000011176 pooling Methods 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 108091093088 Amplicon Proteins 0.000 claims description 2
- 108091026890 Coding region Proteins 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims 2
- 230000008021 deposition Effects 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 230000009258 tissue cross reactivity Effects 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000035772 mutation Effects 0.000 description 9
- 230000003321 amplification Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 210000005259 peripheral blood Anatomy 0.000 description 6
- 239000011886 peripheral blood Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 208000036832 Adenocarcinoma of ovary Diseases 0.000 description 1
- 108091008875 B cell receptors Proteins 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 229940045513 CTLA4 antagonist Drugs 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010061328 Ovarian epithelial cancer Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000002619 cancer immunotherapy Methods 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108091008915 immune receptors Proteins 0.000 description 1
- 102000027596 immune receptors Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000013394 immunophenotyping Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001806 memory b lymphocyte Anatomy 0.000 description 1
- 208000013371 ovarian adenocarcinoma Diseases 0.000 description 1
- 201000006588 ovary adenocarcinoma Diseases 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2016/053598 | 2016-09-24 | ||
| PCT/US2016/053598 WO2017053905A1 (en) | 2015-09-24 | 2016-09-24 | Affinity-oligonucleotide conjugates and uses thereof |
| PCT/US2017/013274 WO2018057051A1 (en) | 2016-09-24 | 2017-01-12 | Affinity-oligonucleotide conjugates and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019537430A JP2019537430A (ja) | 2019-12-26 |
| JP2019537430A5 true JP2019537430A5 (enExample) | 2020-02-20 |
| JP6929354B2 JP6929354B2 (ja) | 2021-09-01 |
Family
ID=57960826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515986A Expired - Fee Related JP6929354B2 (ja) | 2016-09-24 | 2017-01-12 | 親和性−オリゴヌクレオチドコンジュゲートおよびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP6929354B2 (enExample) |
| AU (1) | AU2017332495A1 (enExample) |
| BR (1) | BR112019005748A2 (enExample) |
| IL (1) | IL265471A (enExample) |
| WO (1) | WO2018057051A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US12258613B2 (en) * | 2017-03-08 | 2025-03-25 | California Institute Of Technology | Pairing antigen specificity of a T cell with T cell receptor sequences |
| SG11201907762RA (en) | 2017-03-24 | 2019-10-30 | Nat Univ Singapore | Methods for multiplex detection of molecules |
| CN111148849A (zh) | 2017-05-26 | 2020-05-12 | 阿布维托有限责任公司 | 高通量多核苷酸文库测序和转录组分析 |
| SG11202007686VA (en) | 2018-02-12 | 2020-09-29 | 10X Genomics Inc | Methods characterizing multiple analytes from individual cells or cell populations |
| WO2019217758A1 (en) | 2018-05-10 | 2019-11-14 | 10X Genomics, Inc. | Methods and systems for molecular library generation |
| JP7145980B2 (ja) * | 2018-06-15 | 2022-10-03 | エフ．ホフマン－ラ ロシュ アーゲー | 腫瘍浸潤リンパ球にて発現するｔ細胞受容体により認識される抗原を識別するためのシステム |
| KR20210063379A (ko) * | 2018-09-24 | 2021-06-01 | 브리스톨-마이어스 스큅 컴퍼니 | 바코딩된 펩티드-mhc 복합체 및 그의 용도 |
| GB201816522D0 (en) * | 2018-10-10 | 2018-11-28 | Autolus Ltd | Methods and reagents for analysing nucleic acids from single cells |
| CA3124432A1 (en) * | 2018-12-18 | 2020-06-25 | Mbl International Corp. | Compositions of streptavidin-oligo conjugates of pmhc occupancy |
| EP3912992A4 (en) * | 2019-02-04 | 2022-11-23 | National University Corporation Ehime University | Car library and production method for scfv |
| WO2021150821A1 (en) * | 2020-01-24 | 2021-07-29 | Vanderbilt University | Methods for identification of ligand-blocking antibodies and for determining antibody potency |
| US12449419B1 (en) | 2020-02-12 | 2025-10-21 | 10X Genomics, Inc. | Methods for detecting binding of peptide-MHC monomers to T cells |
| EP4162077A4 (en) * | 2020-06-09 | 2024-07-03 | Simsen Diagnostics AB | DETERMINATION OF LYMPHOCYTE CLANITY |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US5019384A (en) | 1986-06-30 | 1991-05-28 | Massachusetts Institute Of Technology | Immunonodulating compositions and their use |
| US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
| AU631802B2 (en) | 1988-06-14 | 1992-12-10 | Cetus Oncology Corporation | Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom |
| US5168038A (en) | 1988-06-17 | 1992-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | In situ transcription in cells and tissues |
| US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
| US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5733523A (en) | 1990-12-10 | 1998-03-31 | Akzo Nobel N.V. | Targeted delivery of a therapeutic entity using complementary oligonucleotides |
| JP3266311B2 (ja) | 1991-05-02 | 2002-03-18 | 生化学工業株式会社 | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 |
| US5550215A (en) | 1991-11-22 | 1996-08-27 | Holmes; Christopher P. | Polymer reversal on solid surfaces |
| AU675054B2 (en) | 1991-11-22 | 1997-01-23 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
| US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
| US5491074A (en) | 1993-04-01 | 1996-02-13 | Affymax Technologies Nv | Association peptides |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
| US6090555A (en) | 1997-12-11 | 2000-07-18 | Affymetrix, Inc. | Scanned image alignment systems and methods |
| US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| DE69503126T2 (de) | 1994-05-05 | 1998-11-12 | Beckman Instruments Inc | Repetitive oligonukleotide matrix |
| US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
| US5795716A (en) | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
| US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
| US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
| US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| SE504798C2 (sv) | 1995-06-16 | 1997-04-28 | Ulf Landegren | Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten |
| US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
| US6852487B1 (en) | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| JP2000512744A (ja) | 1996-05-16 | 2000-09-26 | アフィメトリックス，インコーポレイテッド | 標識材料を検出するシステムおよび方法 |
| EP2369007B1 (en) | 1996-05-29 | 2015-07-29 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| AU726501B2 (en) | 1996-06-04 | 2000-11-09 | University Of Utah Research Foundation | Monitoring hybridization during PCR |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| ES2209145T5 (es) | 1997-05-28 | 2009-10-30 | Crescendo Biologics Ltd. | Complejos de ribosomas como particulas de seleccion para el desarrollo in vitro y evolucion de proteinas. |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| US6269846B1 (en) | 1998-01-13 | 2001-08-07 | Genetic Microsystems, Inc. | Depositing fluid specimens on substrates, resulting ordered arrays, techniques for deposition of arrays |
| US6428752B1 (en) | 1998-05-14 | 2002-08-06 | Affymetrix, Inc. | Cleaning deposit devices that form microarrays and the like |
| US6054276A (en) | 1998-02-23 | 2000-04-25 | Macevicz; Stephen C. | DNA restriction site mapping |
| US5936324A (en) | 1998-03-30 | 1999-08-10 | Genetic Microsystems Inc. | Moving magnet scanner |
| WO1999057321A1 (en) | 1998-05-01 | 1999-11-11 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| US6780591B2 (en) | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
| EP1165839A2 (en) | 1999-03-26 | 2002-01-02 | Whitehead Institute For Biomedical Research | Universal arrays |
| US6582938B1 (en) | 2001-05-11 | 2003-06-24 | Affymetrix, Inc. | Amplification of nucleic acids |
| US7306904B2 (en) | 2000-02-18 | 2007-12-11 | Olink Ab | Methods and kits for proximity probing |
| US6686184B1 (en) | 2000-05-25 | 2004-02-03 | President And Fellows Of Harvard College | Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks |
| JP4317940B2 (ja) | 2001-08-31 | 2009-08-19 | イミュノコア・リミテッド | 物質 |
| GB0127564D0 (en) | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
| JP2006507921A (ja) | 2002-06-28 | 2006-03-09 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 流体分散のための方法および装置 |
| US7569664B2 (en) | 2002-10-09 | 2009-08-04 | Immunocore Limited | Single chain recombinant T cell receptors |
| US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
| WO2004091763A2 (en) | 2003-04-10 | 2004-10-28 | President And Fellows Of Harvard College | Formation and control of fluidic species |
| EP2662136A3 (en) | 2003-08-27 | 2013-12-25 | President and Fellows of Harvard College | Method for handling and mixing droplets |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
| US7643818B2 (en) | 2004-11-22 | 2010-01-05 | Seven Networks, Inc. | E-mail messaging to/from a mobile terminal |
| EP1861194A2 (en) | 2005-03-04 | 2007-12-05 | The President and Fellows of Harvard College | Method and apparatus for forming multiple emulsions |
| US8592136B2 (en) | 2005-09-13 | 2013-11-26 | Affymetrix, Inc. | Methods for producing codes for microparticles |
| EP3913375A1 (en) | 2006-01-11 | 2021-11-24 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| DE602007009811D1 (de) | 2006-01-27 | 2010-11-25 | Harvard College | Koaleszenz fluider tröpfchen |
| GB0605584D0 (en) | 2006-03-20 | 2006-04-26 | Olink Ab | Method for analyte detection using proximity probes |
| EP2021113A2 (en) | 2006-05-11 | 2009-02-11 | Raindance Technologies, Inc. | Microfluidic devices |
| CN102083575B (zh) | 2007-06-25 | 2014-09-17 | 阿费梅特里克斯公司 | 刻印的微码 |
| EP2644707B1 (en) | 2008-04-30 | 2015-06-03 | Integrated Dna Technologies, Inc. | RNase-H-based assays utilizing modified RNA monomers |
| US8911948B2 (en) | 2008-04-30 | 2014-12-16 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
| CN102405402A (zh) | 2008-09-23 | 2012-04-04 | 阔达生命有限公司 | 基于液滴的测定系统 |
| US10464987B2 (en) | 2009-10-06 | 2019-11-05 | Abbvie Inc. | Human single-chain T cell receptors |
| HK1221013A1 (zh) * | 2013-03-15 | 2017-05-19 | 普罗格诺西斯生物科学公司 | 用於检测肽/mhc/tcr结合的方法 |
| US10119134B2 (en) * | 2013-03-15 | 2018-11-06 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| EP3628684B1 (en) * | 2014-06-06 | 2024-09-18 | Herlev Hospital | Determining antigen recognition through barcoding of mhc multimers |
| SG10201911069WA (en) * | 2014-09-15 | 2020-01-30 | Abvitro Llc | High-throughput nucleotide library sequencing |
| WO2016100977A1 (en) * | 2014-12-19 | 2016-06-23 | The Broad Institute Inc. | Methods for profiling the t-cel- receptor repertoire |
-
2017
- 2017-01-12 WO PCT/US2017/013274 patent/WO2018057051A1/en not_active Ceased
- 2017-01-12 JP JP2019515986A patent/JP6929354B2/ja not_active Expired - Fee Related
- 2017-01-12 BR BR112019005748A patent/BR112019005748A2/pt not_active Application Discontinuation
- 2017-01-12 AU AU2017332495A patent/AU2017332495A1/en not_active Abandoned
-
2019
- 2019-03-19 IL IL265471A patent/IL265471A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019537430A5 (enExample) | ||
| JP2018535652A5 (enExample) | ||
| US20240384333A1 (en) | Methods and compositions for identifying or quantifying targets in a biological sample | |
| JP7196143B2 (ja) | 細胞の選択された部分集団中の複数エピトープを識別するための方法 | |
| EP3268462B1 (en) | Genotype and phenotype coupling | |
| Stoeckius et al. | Large-scale simultaneous measurement of epitopes and transcriptomes in single cells | |
| Savage et al. | A kinetic window constricts the T cell receptor repertoire in the thymus | |
| US20230408514A1 (en) | Single-cell combinatorial indexed cytometry sequencing | |
| JP7145980B2 (ja) | 腫瘍浸潤リンパ球にて発現するｔ細胞受容体により認識される抗原を識別するためのシステム | |
| CA3135619A1 (en) | Methods and systems to characterize tumors and identify tumor heterogeneity | |
| US11365441B2 (en) | Method and apparatus for simultaneous targeted sequencing of DNA, RNA and protein | |
| EP2588608B1 (en) | Psa binding aptamer and method for diagnosis of prostate cancer | |
| US20230212673A1 (en) | Lymphocyte clonality determination | |
| Schnormeier et al. | Single Cell VDJ Sequencing of Normal and Malignant B and T Cells | |
| US20240200127A1 (en) | A method for identifying lead sequences | |
| US20200325522A1 (en) | Method and systems to characterize tumors and identify tumor heterogeneity | |
| US20220034881A1 (en) | Barcoded peptide-mhc complexes and uses thereof | |
| US20060204971A1 (en) | Oligonucleotides for multiplexed binding assays | |
| Zhang | Hit Identification and Hit Follow‐Up | |
| US20180112210A1 (en) | Broad-spectrum serological diagnostics and uses thereof | |
| CYTOKINES | " Department of Medicine, Division of Immunology and Rheumatology;“Stanford | |
| Domenyuk et al. | Let us know how access to this document benefits yo u |